KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX)

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / COMMON STOCK
Total 13F shares
67,404,672
Share change
-1,205,140
Total reported value
$1,036,672,414
Put/Call ratio
74%
Price per share
$15.38
Number of holders
134
Value change
-$29,160,570
Number of buys
63
Number of sells
78

Institutional Holders of KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) as of Q2 2014

As of 30 Jun 2014, KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX) was held by 134 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 67,404,672 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, VANGUARD GROUP INC, DEERFIELD MANAGEMENT CO, FMR LLC, Sectoral Asset Management Inc, Camber Capital Management LLC, FRANKLIN RESOURCES INC, State Street Corp, BlackRock Institutional Trust Company, N.A., and OAK RIDGE INVESTMENTS LLC. This page lists 134 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.